🇺🇸 FDA
Patent

US 10800775

Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same

granted A61KA61K31/437A61K45/06

Quick answer

US patent 10800775 (Pyrazolyl pyrrolo[2,3-b]pyrmidine-5-carboxylate analogs and methods of making the same) held by Aclaris Therapeutics, Inc. expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aclaris Therapeutics, Inc.
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/437, A61K45/06